Result of two randomized trials comparing nolatrexed (Thymitaq™) versus methotrexate in patients with recurrent head and neck cancer
Titel:
Result of two randomized trials comparing nolatrexed (Thymitaq™) versus methotrexate in patients with recurrent head and neck cancer
Auteur:
Pivot, X. Wadler, S. Kelly, C. Ruxer, R. Tortochaux, J. Stern, J. Belpomme, D. Humblet, Y. Domenge, C. Clendeninn, N. Johnston, A. Penning, C. Schneider, M.